Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 617

1.
2.

Prediction of relapses in PR3-ANCA-associated vasculitis by assessing responses of ANCA titres to treatment.

Sanders JS, Huitma MG, Kallenberg CG, Stegeman CA.

Rheumatology (Oxford). 2006 Jun;45(6):724-9. Epub 2006 Jan 6.

3.

Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis.

Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH.

Ann Intern Med. 2005 Nov 1;143(9):621-31.

PMID:
16263884
5.

[ANCA-associated vasculitis].

Sinico RA, Sabadini E, Boeri R, Radice A.

G Ital Nefrol. 2002 Mar-Apr;19(2):125-36. Review. Italian.

PMID:
12195410
6.

ANCA-associated vasculitis with renal involvement: an outcome analysis.

Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD.

Nephrol Dial Transplant. 2004 Jun;19(6):1403-11. Epub 2004 Apr 6.

7.

A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.

Jayne D, Rasmussen N, Andrassy K, Bacon P, Tervaert JW, Dadoniené J, Ekstrand A, Gaskin G, Gregorini G, de Groot K, Gross W, Hagen EC, Mirapeix E, Pettersson E, Siegert C, Sinico A, Tesar V, Westman K, Pusey C; European Vasculitis Study Group.

N Engl J Med. 2003 Jul 3;349(1):36-44.

8.
9.

[Clinical features and outcomes of hyperthyroidism patients positive in propylthiouracil-induced antineutrophil cytoplasmic antibody].

Ye H, Gao Y, Guo XH, Zhao MH.

Zhonghua Yi Xue Za Zhi. 2005 Dec 14;85(47):3323-7. Chinese.

PMID:
16409836
10.

Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis.

Finkielman JD, Merkel PA, Schroeder D, Hoffman GS, Spiera R, St Clair EW, Davis JC Jr, McCune WJ, Lears AK, Ytterberg SR, Hummel AM, Viss MA, Peikert T, Stone JH, Specks U; WGET Research Group.

Ann Intern Med. 2007 Nov 6;147(9):611-9.

PMID:
17975183
12.

Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.

De Groot K, Rasmussen N, Bacon PA, Tervaert JW, Feighery C, Gregorini G, Gross WL, Luqmani R, Jayne DR.

Arthritis Rheum. 2005 Aug;52(8):2461-9.

13.

Factors influencing patient survival and renal function outcome in pulmonary-renal syndrome associated with ANCA (+) vasculitis: a single-center experience.

Stangou M, Asimaki A, Bamichas G, Christidou F, Zoumbaridis N, Natse T, Galanis N, Christaki P, Patakas D, Sombolos K.

J Nephrol. 2005 Jan-Feb;18(1):35-44.

PMID:
15772921
15.

Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.

Pagnoux C, Mahr A, Hamidou MA, Boffa JJ, Ruivard M, Ducroix JP, Kyndt X, Lifermann F, Papo T, Lambert M, Le Noach J, Khellaf M, Merrien D, Puéchal X, Vinzio S, Cohen P, Mouthon L, Cordier JF, Guillevin L; French Vasculitis Study Group.

N Engl J Med. 2008 Dec 25;359(26):2790-803. doi: 10.1056/NEJMoa0802311.

16.
19.

Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases.

Chen YX, Yu HJ, Ni LY, Zhang W, Xu YW, Ren H, Chen XN, Wang XL, Li X, Pan XX, Wang WM, Chen N.

J Rheumatol. 2007 Dec;34(12):2451-6. Epub 2007 Nov 1.

PMID:
17985400
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk